HPV E6/E7 oncogene-targeted mRNA inhibitors (Hubei University of Medicine)

N/A

Report date: 2025/03/20 14:46:24
NME

Base Information

Drug NameHPV E6/E7 oncogene-targeted mRNA inhibitors (Hubei University of Medicine)
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionProtein E6 inhibitorsProtein E7 inhibitors
TargetsProtein E6Protein E7
Therapy Area/IndicationsUterine Cervical Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesHubei University of Medicine
China Registration ClassN/A

Develop Information

Active CompaniesHubei University of Medicine
Inactive CompaniesN/A
Active IndicationsUterine Cervical Neoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A